Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol.

@article{Filipo2010IntratympanicPT,
  title={Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol.},
  author={Roberto Filipo and Edoardo Covelli and Giorgio Balsamo and Giuseppe Attanasio},
  journal={Acta oto-laryngologica},
  year={2010},
  volume={130 11},
  pages={1209-13}
}
CONCLUSION Intratympanic administration of prednisolone at a dose of 62.5 mg/ml performed every day for 3 consecutive days is more efficacious than the therapeutic approaches described so far in the literature. OBJECTIVES The aim of the study was to evaluate the overall success rate, morbidity, and prognostic factors of a new protocol of intratympanic steroid administration as a means of primary therapy for idiopathic sensorineural hearing loss. METHODS Overall, 34 patients presenting… CONTINUE READING